Clinical relevance of the borderline results of the Hybrid Capture 2 High-Risk HPV DNA assay with cervical samples collected in Specimen Transport Medium
, , , , , e
24 set 2019
INFORMAZIONI SU QUESTO ARTICOLO
Categoria dell'articolo: Research Article
Pubblicato online: 24 set 2019
Pagine: 316 - 322
Ricevuto: 10 lug 2019
Accettato: 06 ago 2019
DOI: https://doi.org/10.2478/raon-2019-0044
Parole chiave
© 2019 Jerneja Varl, Urska Ivanus, Ziva Pohar Marinsek, Tine Jerman, Anja Ostrbenk Valencak, Mario Poljak, Veronika Kloboves Prevodnik, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Varl, Jerneja
Department of Experimental Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
University of Ljubljana, Faculty of MedicineLjubljana, Slovenia
Ivanus, Urska
ZORA National Cervical Cancer Screening Programme, Epidemiology and Cancer Registry, Institute of Oncology LjubljanaLjubljana, Slovenia
Marinsek, Ziva Pohar
Department of Cytopathology, Institute of Oncology LjubljanaLjubljana, Slovenia
Jerman, Tine
ZORA National Cervical Cancer Screening Programme, Epidemiology and Cancer Registry, Institute of Oncology LjubljanaLjubljana, Slovenia
Valencak, Anja Ostrbenk
Institute of Microbiology and Immunology, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Poljak, Mario
Institute of Microbiology and Immunology, Faculty of Medicine, University of LjubljanaLjubljana, Slovenia
Prevodnik, Veronika Kloboves
Department of Cytopathology, Institute of Oncology LjubljanaLjubljana, Slovenia